nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Mood swings—Epirubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Ganciclovir—Cerebrovascular accident—Doxorubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Ganciclovir—Pruritus—Sorafenib—liver cancer	0.00143	0.00143	CcSEcCtD
Ganciclovir—Ataxia—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Ganciclovir—Blood creatinine increased—Epirubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Ganciclovir—Dehydration—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Ganciclovir—Hyponatraemia—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Ganciclovir—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Ganciclovir—Pain in extremity—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Ganciclovir—Liver function test abnormal—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Ganciclovir—Dry skin—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Ganciclovir—Affect lability—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Ganciclovir—Migraine—Doxorubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Ganciclovir—Hypokalaemia—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Ganciclovir—Diarrhoea—Sorafenib—liver cancer	0.00138	0.00138	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Ganciclovir—Nasopharyngitis—Epirubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Ganciclovir—Face oedema—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Ganciclovir—Gastritis—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Ganciclovir—Muscular weakness—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Ganciclovir—Cardiac arrest—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Ganciclovir—Dizziness—Sorafenib—liver cancer	0.00133	0.00133	CcSEcCtD
Ganciclovir—Mood swings—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Ganciclovir—Abdominal distension—Epirubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Ganciclovir—Ataxia—Doxorubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Ganciclovir—Blood creatinine increased—Doxorubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Ganciclovir—Dysphagia—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Ganciclovir—Dehydration—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Ganciclovir—Eosinophilia—Epirubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Ganciclovir—Liver function test abnormal—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Ganciclovir—Dry skin—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Ganciclovir—Pancreatitis—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Ganciclovir—Vomiting—Sorafenib—liver cancer	0.00128	0.00128	CcSEcCtD
Ganciclovir—Hypokalaemia—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Ganciclovir—Rash—Sorafenib—liver cancer	0.00127	0.00127	CcSEcCtD
Ganciclovir—Dermatitis—Sorafenib—liver cancer	0.00127	0.00127	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Ganciclovir—Headache—Sorafenib—liver cancer	0.00126	0.00126	CcSEcCtD
Ganciclovir—Nasopharyngitis—Doxorubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Ganciclovir—Pancytopenia—Epirubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Ganciclovir—Gastritis—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Ganciclovir—Muscular weakness—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Ganciclovir—Neutropenia—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Ganciclovir—Dysuria—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Ganciclovir—Abdominal distension—Doxorubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Ganciclovir—Dysphagia—Doxorubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Ganciclovir—Pollakiuria—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Ganciclovir—Eosinophilia—Doxorubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Ganciclovir—Nausea—Sorafenib—liver cancer	0.0012	0.0012	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Ganciclovir—Pancreatitis—Doxorubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Ganciclovir—Weight decreased—Epirubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Ganciclovir—Hyperglycaemia—Epirubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Ganciclovir—Pneumonia—Epirubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Ganciclovir—Infestation—Epirubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Ganciclovir—Infestation NOS—Epirubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Ganciclovir—Pancytopenia—Doxorubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Ganciclovir—Renal failure—Epirubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Epirubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Ganciclovir—Stomatitis—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Ganciclovir—Jaundice—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Ganciclovir—Conjunctivitis—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Ganciclovir—Urinary tract infection—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Ganciclovir—Dysuria—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Ganciclovir—Neutropenia—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Ganciclovir—Sweating—Epirubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Ganciclovir—Haematuria—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Epirubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Ganciclovir—Agranulocytosis—Epirubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00107	0.00107	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Ganciclovir—Haemoglobin—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—liver cancer	0.000992	0.000992	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—liver cancer	0.000978	0.000978	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—liver cancer	0.000975	0.000975	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—liver cancer	0.000973	0.000973	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—liver cancer	0.00097	0.00097	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—liver cancer	0.00097	0.00097	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—liver cancer	0.000966	0.000966	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—liver cancer	0.000963	0.000963	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—liver cancer	0.000958	0.000958	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—liver cancer	0.000956	0.000956	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—liver cancer	0.000954	0.000954	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—liver cancer	0.000952	0.000952	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—liver cancer	0.000951	0.000951	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—liver cancer	0.000945	0.000945	CcSEcCtD
Ganciclovir—Chills—Epirubicin—liver cancer	0.000941	0.000941	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—liver cancer	0.000937	0.000937	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—liver cancer	0.000935	0.000935	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—liver cancer	0.000927	0.000927	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—liver cancer	0.000919	0.000919	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—liver cancer	0.000918	0.000918	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—liver cancer	0.000913	0.000913	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—liver cancer	0.000905	0.000905	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—liver cancer	0.0009	0.0009	CcSEcCtD
Ganciclovir—Tension—Epirubicin—liver cancer	0.000896	0.000896	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—liver cancer	0.000894	0.000894	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—liver cancer	0.000887	0.000887	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—liver cancer	0.000883	0.000883	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—liver cancer	0.00088	0.00088	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—liver cancer	0.000878	0.000878	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—liver cancer	0.000875	0.000875	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—liver cancer	0.000871	0.000871	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—liver cancer	0.000867	0.000867	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—liver cancer	0.00086	0.00086	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—liver cancer	0.000858	0.000858	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—liver cancer	0.00085	0.00085	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—liver cancer	0.000847	0.000847	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—liver cancer	0.000845	0.000845	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—liver cancer	0.000844	0.000844	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—liver cancer	0.000839	0.000839	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—liver cancer	0.000832	0.000832	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—liver cancer	0.000829	0.000829	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—liver cancer	0.000827	0.000827	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—liver cancer	0.000823	0.000823	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—liver cancer	0.000821	0.000821	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—liver cancer	0.00082	0.00082	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—liver cancer	0.000817	0.000817	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—liver cancer	0.000817	0.000817	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—liver cancer	0.000812	0.000812	CcSEcCtD
Ganciclovir—Cough—Epirubicin—liver cancer	0.000797	0.000797	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—liver cancer	0.000796	0.000796	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—liver cancer	0.000791	0.000791	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—liver cancer	0.000788	0.000788	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—liver cancer	0.000784	0.000784	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—liver cancer	0.000781	0.000781	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—liver cancer	0.000777	0.000777	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—liver cancer	0.000777	0.000777	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—liver cancer	0.000777	0.000777	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—liver cancer	0.000776	0.000776	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—liver cancer	0.000775	0.000775	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000772	0.000772	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—liver cancer	0.000768	0.000768	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—liver cancer	0.000762	0.000762	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—liver cancer	0.00076	0.00076	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—liver cancer	0.000759	0.000759	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—liver cancer	0.000756	0.000756	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—liver cancer	0.000751	0.000751	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—liver cancer	0.000745	0.000745	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—liver cancer	0.000745	0.000745	CcSEcCtD
Ganciclovir—Infection—Epirubicin—liver cancer	0.00074	0.00074	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—liver cancer	0.000737	0.000737	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—liver cancer	0.000732	0.000732	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—liver cancer	0.00073	0.00073	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—liver cancer	0.000729	0.000729	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—liver cancer	0.000727	0.000727	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—liver cancer	0.000724	0.000724	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—liver cancer	0.00072	0.00072	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—liver cancer	0.000719	0.000719	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—liver cancer	0.000719	0.000719	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—liver cancer	0.000719	0.000719	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—liver cancer	0.000717	0.000717	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000714	0.000714	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—liver cancer	0.000711	0.000711	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—liver cancer	0.00071	0.00071	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—liver cancer	0.000703	0.000703	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—liver cancer	0.000696	0.000696	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—liver cancer	0.000695	0.000695	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—liver cancer	0.000689	0.000689	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—liver cancer	0.000689	0.000689	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—liver cancer	0.000685	0.000685	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000679	0.000679	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—liver cancer	0.000675	0.000675	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—liver cancer	0.000674	0.000674	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—liver cancer	0.000673	0.000673	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—liver cancer	0.00067	0.00067	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—liver cancer	0.000669	0.000669	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—liver cancer	0.000667	0.000667	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—liver cancer	0.000664	0.000664	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—liver cancer	0.000662	0.000662	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—liver cancer	0.000657	0.000657	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—liver cancer	0.000656	0.000656	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—liver cancer	0.000648	0.000648	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—liver cancer	0.000644	0.000644	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000643	0.000643	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—liver cancer	0.000642	0.000642	CcSEcCtD
Ganciclovir—Pain—Epirubicin—liver cancer	0.000637	0.000637	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—liver cancer	0.000637	0.000637	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000628	0.000628	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—liver cancer	0.000624	0.000624	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—liver cancer	0.000619	0.000619	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—liver cancer	0.000615	0.000615	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—liver cancer	0.000614	0.000614	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—liver cancer	0.000613	0.000613	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—liver cancer	0.000609	0.000609	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—liver cancer	0.000607	0.000607	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—liver cancer	0.000599	0.000599	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000595	0.000595	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—liver cancer	0.000594	0.000594	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—liver cancer	0.000592	0.000592	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—liver cancer	0.00059	0.00059	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—liver cancer	0.00059	0.00059	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—liver cancer	0.000589	0.000589	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—liver cancer	0.000589	0.000589	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—liver cancer	0.000568	0.000568	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000564	0.000564	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—liver cancer	0.000549	0.000549	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—liver cancer	0.000548	0.000548	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—liver cancer	0.000545	0.000545	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—liver cancer	0.000545	0.000545	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—liver cancer	0.000535	0.000535	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—liver cancer	0.000527	0.000527	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—liver cancer	0.00051	0.00051	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—liver cancer	0.000508	0.000508	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—liver cancer	0.000495	0.000495	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—liver cancer	0.000493	0.000493	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—liver cancer	0.000488	0.000488	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—liver cancer	0.000474	0.000474	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—liver cancer	0.000472	0.000472	CcSEcCtD
Ganciclovir—Rash—Epirubicin—liver cancer	0.00047	0.00047	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—liver cancer	0.000469	0.000469	CcSEcCtD
Ganciclovir—Headache—Epirubicin—liver cancer	0.000467	0.000467	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—liver cancer	0.000456	0.000456	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—liver cancer	0.000443	0.000443	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—liver cancer	0.000438	0.000438	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—liver cancer	0.000435	0.000435	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—liver cancer	0.000434	0.000434	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—liver cancer	0.000432	0.000432	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—liver cancer	0.00041	0.00041	CcSEcCtD
